491 related articles for article (PubMed ID: 33576464)
1. Severe acute respiratory syndrome coronavirus 2 for physicians: Molecular characteristics and host immunity (Review).
Shang J; Du L; Han N; Lv D; Wang J; Yang H; Bai L; Tang H
Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 33576464
[TBL] [Abstract][Full Text] [Related]
2. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
3. The expression of hACE2 receptor protein and its involvement in SARS-CoV-2 entry, pathogenesis, and its application as potential therapeutic target.
Al-Zaidan L; Mestiri S; Raza A; Merhi M; Inchakalody VP; Fernandes Q; Taib N; Uddin S; Dermime S
Tumour Biol; 2021; 43(1):177-196. PubMed ID: 34420993
[TBL] [Abstract][Full Text] [Related]
4. Determining available strategies for prevention and therapy: Exploring COVID‑19 from the perspective of ACE2 (Review).
Cai L; Guo X; Cao Y; Ying P; Hong L; Zhang Y; Yi G; Fu M
Int J Mol Med; 2021 Apr; 47(4):. PubMed ID: 33576441
[TBL] [Abstract][Full Text] [Related]
5. Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis.
Ramasamy S; Subbian S
Clin Microbiol Rev; 2021 Jun; 34(3):. PubMed ID: 33980688
[TBL] [Abstract][Full Text] [Related]
6. COVID-19: Molecular and Cellular Response.
Alipoor SD; Mortaz E; Jamaati H; Tabarsi P; Bayram H; Varahram M; Adcock IM
Front Cell Infect Microbiol; 2021; 11():563085. PubMed ID: 33643932
[TBL] [Abstract][Full Text] [Related]
7. Increasing host cellular receptor-angiotensin-converting enzyme 2 expression by coronavirus may facilitate 2019-nCoV (or SARS-CoV-2) infection.
Zhuang MW; Cheng Y; Zhang J; Jiang XM; Wang L; Deng J; Wang PH
J Med Virol; 2020 Nov; 92(11):2693-2701. PubMed ID: 32497323
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2.
Hatmal MM; Alshaer W; Al-Hatamleh MAI; Hatmal M; Smadi O; Taha MO; Oweida AJ; Boer JC; Mohamud R; Plebanski M
Cells; 2020 Dec; 9(12):. PubMed ID: 33302501
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19.
Kuba K; Yamaguchi T; Penninger JM
Front Immunol; 2021; 12():732690. PubMed ID: 35003058
[TBL] [Abstract][Full Text] [Related]
10. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review.
Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110
[TBL] [Abstract][Full Text] [Related]
11. The Ineluctable Role of ACE-2 Receptors in SARS COV-2 Infection and Drug Repurposing as a Plausible SARS COV-2 Therapy: A Concise Treatise.
Joseph S; Nair B; Nath LR
Curr Mol Med; 2021; 21(10):888-913. PubMed ID: 33563197
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19.
Gusev E; Sarapultsev A; Solomatina L; Chereshnev V
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163638
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 Isolates Show Impaired Replication in Human Immune Cells but Differential Ability to Replicate and Induce Innate Immunity in Lung Epithelial Cells.
Jiang M; Kolehmainen P; Kakkola L; Maljanen S; Melén K; Smura T; Julkunen I; Österlund P
Microbiol Spectr; 2021 Sep; 9(1):e0077421. PubMed ID: 34378952
[TBL] [Abstract][Full Text] [Related]
14. Can SARS-CoV-2 Virus Use Multiple Receptors to Enter Host Cells?
Gadanec LK; McSweeney KR; Qaradakhi T; Ali B; Zulli A; Apostolopoulos V
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498183
[TBL] [Abstract][Full Text] [Related]
15. Host cell entry mediators implicated in the cellular tropism of SARS‑CoV‑2, the pathophysiology of COVID‑19 and the identification of microRNAs that can modulate the expression of these mediators (Review).
Katopodis P; Randeva HS; Spandidos DA; Saravi S; Kyrou I; Karteris E
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34935057
[TBL] [Abstract][Full Text] [Related]
16. SARS‑CoV‑2 spike protein‑induced host inflammatory response signature in human corneal epithelial cells.
Zhu G; Lyu L; Yang H; Liu G; Yang S; Gu C; Wang L; Yan H; Hu M; Che C
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34132373
[TBL] [Abstract][Full Text] [Related]
17. Immunopathogenesis and immunobiology of SARS-CoV-2.
Rabaan AA; Al-Ahmed SH; Al Mutair A; Alhumaid S; Sule AA; Tirupathi R; Fawzy M; Muhammad J; Khan A; Hasan A; Shrestha DB; Sah R; Dhawan M; Tiwari R; Bilal M; Ahmad T; Dhama K
Infez Med; 2021 Jun; 29(2):167-180. PubMed ID: 34061781
[TBL] [Abstract][Full Text] [Related]
18. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants.
Weisblum Y; Schmidt F; Zhang F; DaSilva J; Poston D; Lorenzi JC; Muecksch F; Rutkowska M; Hoffmann HH; Michailidis E; Gaebler C; Agudelo M; Cho A; Wang Z; Gazumyan A; Cipolla M; Luchsinger L; Hillyer CD; Caskey M; Robbiani DF; Rice CM; Nussenzweig MC; Hatziioannou T; Bieniasz PD
Elife; 2020 Oct; 9():. PubMed ID: 33112236
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.
Aboudounya MM; Heads RJ
Mediators Inflamm; 2021; 2021():8874339. PubMed ID: 33505220
[TBL] [Abstract][Full Text] [Related]
20. Receptor utilization of angiotensin-converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV.
Wang Q; Qiu Y; Li JY; Liao CH; Zhou ZJ; Ge XY
Transbound Emerg Dis; 2021 May; 68(3):1046-1053. PubMed ID: 32794346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
